TCRX   $2.77  -2.81% Market Closed After Close 2.73 -1.44%

TScan Therapeutics Inc
Total Cash 297.68M
totalCashPerShare 5.619
EBITDA -106.66M
Total Debt 91.07M
quickRatio 7.717
currentRatio 7.765
Total Revenue 12.20M
debtToEquity 35.684
Revenue/Share 0.23
ROA -0.20164
ROE -0.4684
grossProfits
freeCashflow -38.22M
operatingCashflow -71.24M
earningsGrowth
revenueGrowth -0.83
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -63.64552
profitMargins 0.0
enterpriseValue 73.63M
forwardPE -4.27907
floatShares 25.68M
sharesOutstanding 48.70M
sharesShort 2.24M
sharesShortPriorMonth 1.80M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.01%
heldPercentInstitutions 1.00%
Short Ratio help_outline 10.64%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue 4.822
Price To Book help_outline 1.14
earningsQuarterlyGrowth
netIncomeToCommon -104.41M
trailingEps -0.65%
forwardEps -1.29%
enterpriseToEbitda -0.69
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.29 3Q 2024
institutionsCount 115
lastUpdated Nov. 6, 2024, 6:28 p.m.